EU-India Summit Kicks Off Amidst Warnings Of Impact On Medicines Access 10/02/2012 by William New, Intellectual Property Watch 5 Comments The European Union and India today will engage in a high-level meeting in New Delhi with an agenda that includes energy and climate, research and development, and information and communications technologies. But as they enter the meeting, an international health agency and a powerful health advocacy group have issued statements of concern that intellectual property provisions in a bilateral free trade agreement under negotiation will stifle critical generic medicines production in India, putting thousands of poor patients at risk worldwide.
Philippines: IP Office Cannot Issue Injunctions On Counterfeit Claims 01/12/2011 by Intellectual Property Watch Leave a Comment The Philippines Justice Secretary has issued an opinion that an agency cannot issue an injunction against an alleged counterfeiter as the complainant must be an actual party with an interest in the case.
India: Novartis Hearing Postponed To February 30/11/2011 by Intellectual Property Watch Leave a Comment The Supreme Court in New Delhi has postponed the Novartis v. Union of India hearing. The case will now be heard on 28 February 2012.
US, China Hold High-Level Talks On IP Policy 21/11/2011 by William New, Intellectual Property Watch Leave a Comment The United States and China made notable progress on a range of intellectual property policy issues in cabinet-level meetings ending today, according to the US government.
Global Action To Open Generic Competition For Key AIDS Drug 16/11/2011 by Intellectual Property Watch 1 Comment Public health advocates in a dozen countries worldwide have launched a coordinated campaign to bring about generic competition on a key medicine for HIV/AIDS, currently under patent by a pharmaceutical producer.
Plurilateral Trade Agreements Lack Protections For Users, Intermediaries 27/10/2011 by Intellectual Property Watch 2 Comments The role of online intermediaries in copyright enforcement is on the international negotiating table in recent plurilateral trade agreements. Those negotiating with the US would be advised to examine carefully what is being offered, writes Margot Kaminski.
Philippines IP Office: ‘Our Meeting Is Not Fostering Corporate Greed’ 25/10/2011 by William New, Intellectual Property Watch Leave a Comment The Philippines Intellectual Property Office has issued a statement in response to criticism that an IP enforcement meeting it is hosting this week with numerous corporate representatives “does not favor big corporations.”
WIPO Defends Involvement In IP Enforcement Meeting In The Philippines 24/10/2011 by William New, Intellectual Property Watch 3 Comments The World Intellectual Property Organization, a United Nations agency with nearly 200 member states, is under criticism for its connection with a Western industry-heavy event this week in the Philippines aimed at fighting intellectual property counterfeiting and piracy. The concern from technology industry and consumer advocates is that WIPO is involved in an overly one-sided event and did not sufficiently notify its diverse membership or the public of its activities.
Indian Supreme Court To Hear Novartis Challenge To India’s Patent Law 06/09/2011 by William New, Intellectual Property Watch 6 Comments The Indian Supreme Court today is expected to hear Swiss pharmaceutical company Novartis’ case against a provision of Indian patent law aimed at preventing the extension of drug patents for minor changes in existing products, a practice known as evergreening.
EU-India Agreement In WTO Dispute Raises Bar For EU Drug Seizures 30/07/2011 by William New, Intellectual Property Watch Leave a Comment India and the European Union announced a written agreement yesterday that puts more conditions on EU customs authorities before they can stop shipments of generic pharmaceuticals passing through Europe. No longer is the existence of an EU patent on passing generics sufficient cause to stop shipments. The agreement suspends a World Trade Organization dispute started by India last year.